Walleye Trading’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$255K Sell
1,300
-400
-24% -$77.7K ﹤0.01% 2976
2025
Q4
$295K Sell
1,700
-2,500
-60% -$455K ﹤0.01% 3168
2025
Q3
$800K Sell
4,200
-300
-7% -$53.2K ﹤0.01% 2421
2025
Q2
$808K Sell
4,500
-3,100
-41% -$538K ﹤0.01% 2338
2025
Q1
$1.29M Sell
7,600
-65,600
-90% -$10.8M ﹤0.01% 1901
2024
Q4
$11M Sell
73,200
-1,900
-3% -$296K 0.02% 738
2024
Q3
$11.7M Buy
75,100
+74,700
+18,675% +$11.2M 0.02% 699
2024
Q2
$54.8K Sell
400
-11,700
-97% -$1.6M ﹤0.01% 3557
2024
Q1
$1.61M Sell
12,100
-47,200
-80% -$6.12M ﹤0.01% 1878
2023
Q4
$8.18M Sell
59,300
-48,800
-45% -$6.42M 0.02% 898
2023
Q3
$13.2M Buy
108,100
+24,200
+29% +$3.22M 0.03% 552
2023
Q2
$11.8M Buy
83,900
+66,700
+388% +$9.2M 0.04% 509
2023
Q1
$2.43M Sell
17,200
-46,700
-73% -$6.68M 0.01% 1536
2022
Q4
$10M Buy
63,900
+29,400
+85% +$4.22M 0.03% 664
2022
Q3
$4.23M Sell
34,500
-18,700
-35% -$2.46M 0.01% 1141
2022
Q2
$7.08M Buy
53,200
+3,900
+8% +$531K 0.02% 826
2022
Q1
$6.75M Buy
49,300
+15,700
+47% +$2.19M 0.02% 823
2021
Q4
$5.81M Buy
33,600
+1,600
+5% +$243K 0.02% 886
2021
Q3
$4.65M Buy
32,000
+10,400
+48% +$1.52M 0.02% 973
2021
Q2
$2.85M Buy
21,600
+19,900
+1,171% +$2.61M 0.01% 1202
2021
Q1
$218K Buy
1,700
+400
+31% +$49.3K ﹤0.01% 3528
2020
Q4
$155K Sell
1,300
-4,400
-77% -$536K ﹤0.01% 3686
2020
Q3
$653K Sell
5,700
-41,100
-88% -$4.86M ﹤0.01% 2011
2020
Q2
$5.33M Buy
46,800
+44,300
+1,772% +$4.7M 0.03% 505
2020
Q1
$201K Sell
2,500
-6,300
-72% -$652K ﹤0.01% 2587
2019
Q4
$940K Sell
8,800
-5,600
-39% -$584K 0.01% 1851
2019
Q3
$1.54M Sell
14,400
-800
-5% -$82.1K 0.01% 1261
2019
Q2
$1.55M Buy
15,200
+13,900
+1,069% +$1.34M 0.01% 1245
2019
Q1
$117K Sell
1,300
-1,400
-52% -$121K ﹤0.01% 3375
2018
Q4
$225K Sell
2,700
-9,000
-77% -$844K ﹤0.01% 3285
2018
Q3
$1.26M Buy
11,700
+400
+4% +$43.9K 0.01% 1822
2018
Q2
$1.24M Buy
11,300
+5,600
+98% +$583K 0.01% 1868
2018
Q1
$572K Buy
+5,700
New +$584K ﹤0.01% 2512
2017
Q4
Sell
-1,800
Closed -$169 4395
2017
Q3
$169 Sell
1,800
-100
-5% -$10.6K ﹤0.01% 3346
2017
Q2
$211 Sell
1,900
-8,300
-81% -$878K ﹤0.01% 3070
2017
Q1
$1K Sell
10,200
-42,100
-80% -$4.01M 0.01% 1641
2016
Q4
$4.8M Buy
52,300
+35,500
+211% +$3.06M 0.03% 465
2016
Q3
$1.42M Sell
16,800
-500
-3% -$42K 0.01% 1249
2016
Q2
$1.41M Sell
17,300
-110,600
-86% -$8.42M 0.01% 1295
2016
Q1
$9.14M Buy
127,900
+3,700
+3% +$248K 0.08% 227
2015
Q4
$8.84M Sell
124,200
-4,200
-3% -$282K 0.09% 220
2015
Q3
$7.89M Buy
128,400
+77,900
+154% +$5.45M 0.07% 202
2015
Q2
$3.66M Sell
50,500
-66,400
-57% -$4.9M 0.04% 434
2015
Q1
$8.98M Sell
116,900
-3,800
-3% -$272K 0.09% 172
2014
Q4
$8.09M Buy
120,700
+113,300
+1,531% +$7.15M 0.07% 186
2014
Q3
$449K Buy
7,400
+2,200
+42% +$136K 0.01% 1423
2014
Q2
$306 Sell
5,200
-2,200
-30% -$129K ﹤0.01% 1659
2014
Q1
$429 Buy
7,400
+7,300
+7,300% +$391K 0.01% 1395
2013
Q4
$5K Sell
100
-5,000
-98% -$297K ﹤0.01% 3444
2013
Q3
$315K Hold
5,100
﹤0.01% 1446
2013
Q2
$309K Buy
+5,100
New +$304K ﹤0.01% 1485

Other funds holding DGX

Walleye Trading's DGX Position: Q1 2026 in Review

Walleye Trading reduced its Quest Diagnostics (DGX) stake by 79% in Q1 2026, selling an estimated $406K and leaving 549 shares worth $108K. The position accounts for ﹤0.01% of the portfolio, ranked #3431.

Walleye Trading first reported a position in DGX in Q2 2013 and has held it in 30 quarters since. The position peaked at $5.92M in Q3 2023. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Walleye Trading held 549 shares of Quest Diagnostics worth $108K as of Q1 2026.
  • Walleye Trading sold 2,092 Quest Diagnostics shares in Q1 2026, an estimated $406K.
  • Quest Diagnostics made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #3431 holding.
  • Walleye Trading first reported a position in Quest Diagnostics in Q2 2013 and has held it in 30 quarters since.
  • Walleye Trading's Quest Diagnostics position peaked at $5.92M in Q3 2023.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.